Jeffrey M. Fryer
Nessuna posizione attualmente
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Jeffrey M.
Fryer is the founder of Rallybio LLC and Rallybio Corp.
(founded in 2018).
At Rallybio Corp., he held the title of Chief Financial Officer & Treasurer until 2023.
He previously worked at Alexion Pharmaceuticals, Inc. as Chief Tax Officer & Vice President from 2008 to 2017.
Mr. Fryer has a graduate degree from the University of Hartford and an undergraduate degree from Bryant University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
RALLYBIO CORPORATION
1.67% | 31/03/2023 | 632 370 ( 1.67% ) | 1 M $ | 31/03/2024 |
Precedenti posizioni note di Jeffrey M. Fryer
| Società | Posizione | Fine |
|---|---|---|
| RALLYBIO CORPORATION | Founder | 01/02/2023 |
| ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/04/2017 |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Founder | - |
Formazione di Jeffrey M. Fryer
| University of Hartford | Graduate Degree |
| Bryant University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| RALLYBIO CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Commercial Services |
- Borsa valori
- Insiders
- Jeffrey M. Fryer
